Strata Critical Medical EPS SRTA
Diluted earnings per share by quarter and over the last twelve months, from 2019.
- Last 12 months, to Jun 30, 2026
- $0.51
- Latest quarter, Q2 FY26
- −$0.12
- Fiscal year 2025
- $0.51
Strata Critical Medical's earnings per share was $0.51 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.12.
Over the five fiscal years to FY2025 it grew 2% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.51 | n/a |
| FY2024 | −$0.36 | n/a |
| FY2023 | −$0.76 | n/a |
| FY2022 | −$0.41 | n/a |
| FY2021 | −$0.85 | −281% |
| FY2020 | $0.47 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.12 | n/a | $0.51 | |
| Q1 FY26 | $0.03 | n/a | $0.58 | |
| Q4 FY25 | −$0.10 | n/a | $0.51 | |
| Q3 FY25 | $0.70 | n/a | $0.49 | |
| Q2 FY25 | −$0.05 | n/a | −$0.24 | |
| Q1 FY25 | −$0.04 | n/a | −$0.34 | |
| Q4 FY24 | −$0.12 | n/a | −$0.36 | |
| Q3 FY24 | −$0.03 | n/a | −$0.69 | |
| Q2 FY24 | −$0.15 | n/a | −$0.66 | |
| Q1 FY24 | −$0.06 | n/a | −$0.68 | |
| Q4 FY23 | −$0.45 | n/a | −$0.76 | |
| Q3 FY23 | $0.00 | n/a | −$0.53 |
Against its peers
Companies in Medical - Care Facilities nearest Strata Critical Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SRTAStrata Critical Medical | $0.51 | |
| VMDViemed Healthcare | $0.36 | +6% a year |
| SBCSBC Medical | $0.47 | +47% a year |
| OMDAOmada Health | $0.06 | |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| PNTGPennant | $0.90 | +15% a year |
| ARDTArdent Health | $0.55 | −70% a year |
| HCSGHealthcare Services | $1.72 | +176% a year |
| PGNYProgyny | $0.92 | +56% a year |
| ADUSAddus HomeCare | $5.70 | +26% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| Peer median | $0.89 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Strata Critical Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.